Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease
- PMID: 31987814
- PMCID: PMC7225072
- DOI: 10.1016/j.yfrne.2020.100820
Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease
Abstract
Risk and resilience in brain health and disease can be influenced by a variety of factors. While there is a growing appreciation to consider sex as one of these factors, far less attention has been paid to sex-specific variables that may differentially impact females such as pregnancy and reproductive history. In this review, we focus on nervous system disorders which show a female bias and for which there is data from basic research and clinical studies pointing to modification in disease risk and progression during pregnancy, postpartum and/or as a result of parity: multiple sclerosis (MS), depression, stroke, and Alzheimer's disease (AD). In doing so, we join others (Shors, 2016; Galea et al., 2018a) in aiming to illustrate the importance of looking beyond sex in neuroscience research.
Keywords: Allogregnanolone; Alzheimer’s disease; Estrogen; Fetal microchimerism; Immune; Maternal; Multiple sclerosis; Postpartum depression; Progesterone; Prolactin; Stroke.
Copyright © 2020 Elsevier Inc. All rights reserved.
References
-
- Abou-Saleh MT, Ghubash R, Karim L, Krymski M, Bhai I (1998) Hormonal aspects of postpartum depression. Psychoneuroendocrinology 23(5):465–475. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
